Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TMRE mitochondrial membrane potential assay kit Guide
2026-09-17
Translate mitochondrial depolarization into actionable data for apoptosis, sodium-overload necrosis, and mitochondrial function analysis. This guide combines the TMRE mitochondrial membrane potential assay kit with a controlled workflow, CCCP validation, and mechanistic interpretation based on recent NECSO research.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Guide
2026-09-17
Turn human IgG binding into a bright, spatially resolved Cy3 readout across immunofluorescence, tissue imaging, flow cytometry, and ELISA. This workflow-focused guide explains how to pair the reagent with orthopoxvirus antibody studies while avoiding species mismatches, autofluorescence, and overinterpretation of binding data.
-
Amitriptyline HCl: Practical Assay Guide
2026-09-16
This guide helps researchers use Amitriptyline HCl (SKU B2231) in controlled neurotransmitter receptor modulation and neuropharmacology workflows. It covers solution preparation, assay controls, storage, and interpretation boundaries; it should not be used as evidence for clinical efficacy or unvalidated disease-model outcomes.
-
DAPT (GSI-IX) for Notch Signaling Assays
2026-09-16
DAPT (GSI-IX) provides a controllable way to inhibit γ-secretase while separating Notch-dependent phenotypes from broader cellular effects. This guide translates angiogenesis findings from a critical limb ischemia study into practical cell-based workflows, dose planning, validation strategies, and troubleshooting steps.
-
β-Pseudouridine in RNA Vaccine Assay Design
2026-09-15
β-Pseudouridine connects RNA modification biology with rigorous vaccine-platform comparisons. This article explains how to distinguish nucleoside chemistry from self-amplifying RNA effects and design assays that measure structure, translation, and translational fidelity without overclaiming causality.
-
PPT: A Decision Framework for ERα–LUAD Studies
2026-09-15
PPT (Propyl Pyrazole Triol) enables selective interrogation of ERα signaling in female lung adenocarcinoma. This guide translates biomarker-network evidence into a practical framework for separating receptor competence, transcriptional response, and disease-associated mechanism.
-
Multimodal Radiopathomics Predicts Gastric Cancer Response
2026-09-14
This reference study integrates baseline computed tomography and digital H&E pathology with interpretable machine learning to predict response to immunotherapy-based combination therapy in gastric cancer. Its radiopathomics signature showed strong discrimination across internal and external cohorts and linked imaging-pathology patterns with immune regulation and memory B-cell infiltration, providing a framework for more biologically informed treatment stratification.
-
Artesunate B3662: Reliable Cell Assays
2026-09-14
A scenario-driven guide to using Artesunate (SKU B3662) in viability, proliferation, and cytotoxicity workflows. It addresses solvent handling, dose interpretation, ferroptosis-focused experiments, and vendor selection using product specifications and published guidance on distinguishing growth inhibition from true cell killing.
-
Puerarin, NO Signaling, and Dental Follicle Osteogenesis
2026-09-13
The reference study identifies nitric oxide signaling as a mechanistic component of puerarin-induced osteogenic differentiation in rat dental follicle cells. By combining osteogenic readouts with L-NMMA-mediated pathway inhibition, it connects NO, cGMP, soluble guanylate cyclase, and PKG-1 signaling to periodontal regeneration research while leaving isoform-specific and translational questions unresolved.
-
Sulfisomidine Workflows for Enzyme and Microbial Studies
2026-09-12
Sulfisomidine, also known as sulfamethin, supports both hPON1 enzyme kinetics and bacterial folate-pathway experiments. Its environmental degradation profile adds a practical matrix-aware dimension for researchers tracking transformation products and evolving toxicity.
-
NF 340: Reframing P2Y11 in Cancer Invasion
2026-09-11
NF 340 provides a receptor-level way to interrogate the QPRT–purinergic signaling axis in breast cancer invasion. This thought-leadership guide connects the anchor study to experimental design, immunology research, inflammation pathway modulation, and translational decision-making without overstating therapeutic evidence.
-
TSA, ERK/FoxO3a, and Autophagic Flux in Pancreatitis
2026-09-11
The reference study identifies impaired ERK/FoxO3a regulation as a mechanistic link between trichostatin A treatment and restoration of autophagic flux in acute pancreatitis. By combining network pharmacology, AR42J-cell experiments, pharmacological pathway perturbation, and rat validation, it provides a framework for testing autophagy-centered interventions while highlighting the limits of inferring pathway causality from inhibitor and activator studies.
-
Isoprinosine Workflows for Herpesvirus Assays
2026-09-10
Isoprinosine, or inosine pranobex, provides a practical host-response perturbation for viral replication, immune signaling, and herpesvirus nuclear-egress experiments. This workflow pairs dose-ranging and orthogonal readouts with the CLCC1 membrane-fusion discovery, helping researchers distinguish immunomodulation from direct effects on viral trafficking.
-
Amitriptyline HCl: Practical QC Protocol
2026-09-10
Amitriptyline HCl provides a defined hydrochloride salt, reported receptor-inhibition values, and high stated solubility for controlled neuropharmacology research workflows. It is suitable for in vitro and ex vivo assay development, but product specifications should not be treated as evidence of clinical efficacy, disease modification, or performance in an unvalidated model.
-
From PRMT6 Mechanism to Translational Protein Data
2026-09-09
A thought-leadership analysis of how PRMT6-mediated antiviral defense research illustrates the importance of rapid, integrity-preserving protein visualization. The article connects mechanistic plant virology with practical gel workflows using InstaBlue Protein Stain Solution while defining appropriate translational boundaries.